DEBBANE RAYMOND purchased 9.1% of their position (150K shares) of LEXICON PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $219.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 2/23/2026ACC: 0001062822-26-000031
Director
Since Feb 2026
+150K
Net shares
Net buyer
$219.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
150K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
$1.44
Trade value
$71.97K
% of position
3.0%
2/19/2026
1.65M→1.70M
Common Stock
Direct
Shares
+100K
Price / share
$1.48
Trade value
$147.79K
% of position
5.9%
2/20/2026
1.70M→1.80M
Total
Net shares
+150K
Net value
$219.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2026 | P · Purchase | +50K | $1.44 | $71.97K | 3.0% | 1.65M | 1.70M |
| Common Stock Direct | 2/20/2026 | P · Purchase | +100K | $1.48 | $147.79K | 5.9% | 1.70M | 1.80M |
| Total | +150K | $219.75K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned5.45M
Common Stock
IndirectShares owned7.36M
Common Stock
IndirectShares owned35.40M
Common Stock
IndirectShares owned1.54M
Total
49.75M indirect49.75M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.45M | Indirect |
| Common Stock | 7.36M | Indirect |
| Common Stock | 35.40M | Indirect |
| Common Stock | 1.54M | Indirect |
| Total | 49.75M | 49.75M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported